Australia's largest stock trading and investment forum Australia's #1 stock forum

SE1

Click for more information

0.00%

0.2¢ sensera limited

Ann: Quarterly Update and Appendix 4C, page-20

First 20 Last

Share
Profile

Follow
athorn

373 Posts.

56

27/04/21

10:26

Post #: 52743300
Share

Originally posted by númenorsherbert: ↑

NanoDx has talked up the test product and it's potential but has essentially failed at even entering the game (possibly multiple times at this point). EUAs are granted every day for firms both smaller and larger than NanoDx and eventually the door will close. I understand that the NanoDx test's features may be hugely beneficial but is the company capable of delivering?

I believe that we at least deserve to know what 'challenges' are now being faced. Does the issue still lie with the cartridge or has that been resolved and there is now something else? Providing clarity on this could be all the difference. I think the market's reaction so far is just.

Expand

Perhaps our Director in charge of Investor Relations should step up and be active

SE1 Price at posting: 5.8¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

AI stocks: What to expect in 2024-25

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

There are more pages in this discussion • 78 more messages in this thread...

First 20 Last

Add SE1 (ASX) to my watchlist